835 related articles for article (PubMed ID: 16778185)
1. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.
Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M
Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185
[TBL] [Abstract][Full Text] [Related]
2. Rapid and sensitive detection of CpG-methylation using methyl-binding (MB)-PCR.
Gebhard C; Schwarzfischer L; Pham TH; Andreesen R; Mackensen A; Rehli M
Nucleic Acids Res; 2006 Jul; 34(11):e82. PubMed ID: 16822855
[TBL] [Abstract][Full Text] [Related]
3. Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia.
Melki JR; Vincent PC; Clark SJ
Cancer Res; 1999 Aug; 59(15):3730-40. PubMed ID: 10446989
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide profiling of promoter methylation in human.
Hatada I; Fukasawa M; Kimura M; Morita S; Yamada K; Yoshikawa T; Yamanaka S; Endo C; Sakurada A; Sato M; Kondo T; Horii A; Ushijima T; Sasaki H
Oncogene; 2006 May; 25(21):3059-64. PubMed ID: 16407832
[TBL] [Abstract][Full Text] [Related]
5. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
[TBL] [Abstract][Full Text] [Related]
6. Distinction of acute lymphoblastic leukemia from acute myeloid leukemia through microarray-based DNA methylation analysis.
Scholz C; Nimmrich I; Burger M; Becker E; Dörken B; Ludwig WD; Maier S
Ann Hematol; 2005 Apr; 84(4):236-44. PubMed ID: 15538567
[TBL] [Abstract][Full Text] [Related]
7. A distinct epigenetic signature at targets of a leukemia protein.
Rossetti S; Hoogeveen AT; Liang P; Stanciu C; van der Spek P; Sacchi N
BMC Genomics; 2007 Feb; 8():38. PubMed ID: 17266773
[TBL] [Abstract][Full Text] [Related]
8. Aberrant CpG island methylation in cancer cell lines arises in the primary cancers from which they were derived.
Ueki T; Walter KM; Skinner H; Jaffee E; Hruban RH; Goggins M
Oncogene; 2002 Mar; 21(13):2114-7. PubMed ID: 11960385
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation analysis using CpG microarrays is impaired in benzopyrene exposed cells.
Sadikovic B; Andrews J; Rodenhiser DI
Toxicol Appl Pharmacol; 2007 Dec; 225(3):300-9. PubMed ID: 17904174
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation.
Campo Dell'Orto M; Banelli B; Giarin E; Accordi B; Trentin L; Romani M; te Kronnie G; Basso G
Oncol Rep; 2007 Aug; 18(2):417-23. PubMed ID: 17611665
[TBL] [Abstract][Full Text] [Related]
11. Epigenomic changes during leukemia cell differentiation: analysis of histone acetylation and cytosine methylation using CpG island microarrays.
Nouzova M; Holtan N; Oshiro MM; Isett RB; Munoz-Rodriguez JL; List AF; Narro ML; Miller SJ; Merchant NC; Futscher BW
J Pharmacol Exp Ther; 2004 Dec; 311(3):968-81. PubMed ID: 15302897
[TBL] [Abstract][Full Text] [Related]
12. HOXA5 is targeted by cell-type-specific CpG island methylation in normal cells and during the development of acute myeloid leukaemia.
Strathdee G; Sim A; Soutar R; Holyoake TL; Brown R
Carcinogenesis; 2007 Feb; 28(2):299-309. PubMed ID: 16861263
[TBL] [Abstract][Full Text] [Related]
13. General transcription factor binding at CpG islands in normal cells correlates with resistance to de novo DNA methylation in cancer cells.
Gebhard C; Benner C; Ehrich M; Schwarzfischer L; Schilling E; Klug M; Dietmaier W; Thiede C; Holler E; Andreesen R; Rehli M
Cancer Res; 2010 Feb; 70(4):1398-407. PubMed ID: 20145141
[TBL] [Abstract][Full Text] [Related]
14. [Screening for differential methylation status by CpG island microarray in the hepatocellular carcinoma cell lines].
Zheng D; Liu BB; Liu YK; Kang XN; Sun L; Guo K; Sun RX; Chen J; Zhao Y
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):891-6. PubMed ID: 19173987
[TBL] [Abstract][Full Text] [Related]
15. DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array analysis.
Foltz G; Yoon JG; Lee H; Ryken TC; Sibenaller Z; Ehrich M; Hood L; Madan A
Oncogene; 2009 Jul; 28(29):2667-77. PubMed ID: 19465937
[TBL] [Abstract][Full Text] [Related]
16. Functional epigenomics identifies genes frequently silenced in prostate cancer.
Lodygin D; Epanchintsev A; Menssen A; Diebold J; Hermeking H
Cancer Res; 2005 May; 65(10):4218-27. PubMed ID: 15899813
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation differences associated with tumor tissues identified by genome scanning analysis.
Liang G; Salem CE; Yu MC; Nguyen HD; Gonzales FA; Nguyen TT; Nichols PW; Jones PA
Genomics; 1998 Nov; 53(3):260-8. PubMed ID: 9799591
[TBL] [Abstract][Full Text] [Related]
18. Abnormal CpG island methylation occurs during in vitro differentiation of human embryonic stem cells.
Shen Y; Chow J; Wang Z; Fan G
Hum Mol Genet; 2006 Sep; 15(17):2623-35. PubMed ID: 16870691
[TBL] [Abstract][Full Text] [Related]
19. Global, comparative analysis of tissue-specific promoter CpG methylation.
Schilling E; Rehli M
Genomics; 2007 Sep; 90(3):314-23. PubMed ID: 17582736
[TBL] [Abstract][Full Text] [Related]
20. Correlation between methylation profile of promoter cpg islands of seven metastasis-associated genes and their expression states in six cell lines of liver origin.
Li JL; Fei Q; Yu J; Zhang HY; Wang P; Zhu JD
Ai Zheng; 2004 Sep; 23(9):985-91. PubMed ID: 15363188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
